Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 25, 373–374 (1 April 2007) | doi:10.1038/nbt0407-373
News in brief
Abstract
Biofuels bandwagon, Cabilly II revoked, again, Acambis retrenchment, Amgen under assault, IGF-1 patent suit settled, French balk at biosimilars, New C-Path initiative, Selected research collaborations
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
